This is the current revision of this page, as edited by Boghog (talk | contribs) at 07:41, 24 November 2024 (+ cat). The present address (URL) is a permanent link to this version.
Revision as of 07:41, 24 November 2024 by Boghog (talk | contribs) (+ cat)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Chemical compoundThis article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Sulfafurazole" – news · newspapers · books · scholar · JSTOR (August 2014) (Learn how and when to remove this message) |
Pharmaceutical compound
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a601049 |
Pregnancy category |
|
Routes of administration | Oral |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Excretion | Excreted unchanged in urine |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.004.418 |
Chemical and physical data | |
Formula | C11H13N3O3S |
Molar mass | 267.30 g·mol |
3D model (JSmol) | |
Melting point | 194 °C (381 °F) |
SMILES
| |
InChI
| |
(what is this?) (verify) |
Sulfafurazole (INN, also known as sulfisoxazole) is a sulfonamide antibacterial with a dimethyl-isoxazole substituent. It possesses antibiotic activity against a wide range of Gram-negative and Gram-positive organisms. It is sometimes given in combination with erythromycin (see erythromycin/Sulfafurazole) or phenazopyridine. It is used locally in a 4% solution or ointment.
References
- Holmes NE, Grauson ML (October 2017). "Sulfonamides". In Paterson DL, McCarthy JS, Mouton JW, Mills J, Grayson ML, Cosgrove SE, Crowe S, Hope W (eds.). Kucers' The Use of Antibiotics (7th ed.). CRC Press. pp. 1571–1624. ISBN 978-1-4987-4796-7.
External links
- Sulfisoxazole at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- MedlinePlus DrugInfo medmaster-a601049
- MedlinePlus DrugInfo medmaster-a601115
- Diseases Database (DDB): 30455
Antibacterials that inhibit nucleic acid (J01E, J01M) | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Antifolates (inhibit bacterial purine metabolism, thereby inhibiting DNA and RNA synthesis) |
| ||||||||||||||||
Quinolones (inhibit bacterial topoisomerase and/or DNA gyrase, thereby inhibiting DNA replication) |
| ||||||||||||||||
Anaerobic DNA inhibitors |
| ||||||||||||||||
RNA synthesis |
| ||||||||||||||||
|
This systemic antibiotic-related article is a stub. You can help Misplaced Pages by expanding it. |